novartis semaglutide Novo Nordisk to launch Ozempic for type 2 diabetes in US Novo inks Ascendis deal to

New findings may help guide doctors when making decisions for patients who have both skin conditions and metabolic disorders

O que L Carnitina

What would work for your body today, not six months ago

Recently, an orally available small molecule GLP1 receptor activator (LY3502970 or OWL833) was reported that shows undetectable arrestin recruitment at the human GLP1 receptor whilst retaining the ability to stimulate cAMP production (Kawai et al., 2020)

Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

Active individuals, such as those who exercise regularly or have physically demanding jobs, need more protein to repair and build muscles